Drugs / BIBT 986 BS
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02254070 | Jun 2003 → Aug 2004 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02254083 | Feb → May 2003 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02259881 | Dec 2002 → May 2003 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02254057 | Jul → Oct 2002 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBT 986 BS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02254083 ↗ |
| Known as | BIBT 986 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02259881 ↗ |
| Route | Intravenous | “IV Infusion Over 30 Minutes” NCT02254057 ↗ |